The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation

Published:2021-10-26 Issue:12 Volume:41 Page:1314-1330
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Ma Lin¹²,Diao Bowen³,Huang Zhaoqin⁴,Wang Bin¹,Yu Jinming¹²,Meng Xiangjiao¹²^ORCID

Affiliation:

1. Cheeloo College of Medicine Shandong University Jinan 250117 Shandong P. R. China

2. Department of Radiation Oncology Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan 250117 Shandong P. R. China

3. Department of Gynecology, First Affiliated Hospital, School of Medicine Shihezi University Shihezi 832061 Xinjiang P. R. China

4. Department of Radiology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan 250117 Shandong P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12229

Reference106 articles.

1. Global Cancer Incidence and Mortality Rates and Trends—An Update

2. Long‐lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non‐small cell lung cancer;Kimura H;Cancer Commun (Lond),2019

3. Comprehensive molecular profiling of lung adenocarcinoma

4. The Impact of Sex and Smoking Status on the Mutational Spectrum of Epidermal Growth Factor Receptor Gene in Non–small Cell Lung Cancer

5. Association Between Age at Diagnosis and the Presence of EGFR Mutations in Female Patients with Resected Non-small Cell Lung Cancer

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy versus personalized therapy for EGFR mutant lung adenocarcinoma resistance to EGFR-tyrosine kinase inhibitors: a retrospective dual-center study;BMC Pulmonary Medicine;2024-02-24

2. Radiomics Features on Enhanced Computed Tomography Predict FOXP3 Expression and Clinical Prognosis in Patients with Head and Neck Squamous Cell Carcinoma;Journal of Imaging Informatics in Medicine;2024-02-20

3. Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy;Journal of Medicinal Chemistry;2024-01-06

4. Chemotherapy versus personalized therapy for EGFR mutant lung adenocarcinoma resistance to EGFR-Tyrosine Kinase Inhibitors: A Retrospective Dual-Center Study;2023-10-11

5. Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma;Vaccines;2023-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3